Under construction – not a live service
Sign in

Lupus (SLE): open trials in China

163 open trials have a site in China. Registry data; only the trial team decides who can take part.

  • NCT05835310

    An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

    Trial Treatment · Phase 3 · AstraZeneca

    Beijing · Changchun · Changsha · Dongguan · Nanjing · Shanghai · Suzhou · Wenzhou · Zhengzhou

    Registry updated 2026-09-30

  • NCT07299422

    A Study of SHR-2173 in Participants With Systemic Lupus Erythematosus

    Trial Treatment · Phase 2 · Guangdong Hengrui Pharmaceutical Co., Ltd

    Chinese Academy of Medical Sciences & Peking Union Medical College Hospital, Beijing · Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai

    Registry updated 2026-09-29

  • NCT07829614

    F182112 Phase Ib Clinical Study for the Treatment of Patients With Systemic Lupus Erythematosus

    Trial Treatment · Phase 1 · Shandong New Time Pharmaceutical Co., LTD

    Renji Hospital Shanghai Jiao Tong University School of Medicine, Shanghai

    Registry updated 2026-09-21

  • NCT07748156

    SNC116 Therapy for Refractory Systemic Lupus Erythematosus

    Trial Treatment · Early phase 1 · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

    The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing

    Registry updated 2026-09-18

  • NCT07447986

    To Evaluate the Efficacy and Safety of SG301 SC Injection in Systemic Lupus Erythematosus

    Trial Treatment · Phase 2 · Hangzhou Sumgen Biotech Co., Ltd.

    Peking University People's Hospital, Beijing · Jilin University First Hospital, Changchun · Jilin Provincial People's Hospital, Changchun · Heping Hospital Affiliated to Changzhi Medical College, Changzhi · Changzhou Second People's Hospital, Changzhou · West China Hospital,Sichuan University, Chengdu · The Second Affiliated Hospital of Chongqing Medical University, Chongqing · Dalian Municipal Central Hospital, Dalian · The First Affiliated Hospital of Gannan Medical University, Ganzhou · Zhujiang Hospital of Southern Medical University, Guangzhou · The First Affiliated Hospital of Guilin Medical University, Guilin · The 2nd Affiliated Hospital of Harbin Medical University, Harbin · Huzhou third people's Hospital, Huzhou · Jingzhou Central Hospital, Jingzhou · Jining First People's Hospital, Jining · The First People's Hospital of Yunnan Prevince, Kunming · Hebei Zhongyuan Petrolium Central Hospital, Langfang · Gansu Provincial Hospital, Lanzhou · The First Hospital of Lanzhou University, Lanzhou · Linfen Central Hospital, Linfen · Luoyang Central Hospital, Luoyang · The First Affiliated Hospital of Henan University of Science and Technology, Luoyang · The First Affiliated Hospital of Guangxi Medical University, Nanning · Pingxiang People's Hospital, Pingxiang · Shenzhen People's Hospital, Shenzhen · Hebei General Hospital, Shijiazhuang · Shiyan People's Hospital, Shiyan · The Second Affiliated Hospital of Soochow University, Suzhou · Shanxi Bethune Hospital, Taiyuan · Second hospital of Shanxi Medical University, Taiyuan · Tianjin Medical University General Hospital, Tianjin · The First Affiliated Hospital of Wenzhou Medical University, Wenzhou · The Central Hospital of Wuhan, Wuhan · Xiamen Hospital of Traditional Chinese Medicine, Xiamen · Xiamen University Affiliated Zhongshan Hospital, Xiamen · Northern Jiangsu People's Hospital, Yangzhou · Yichang Central People's Hospital, Yichang · Yichun People's Hospital, Yichun · People's Hospital of Zhengzhou, Zhengzhou · Zhuzhou Central Hospital, Zhuzhou

    Registry updated 2026-09-17

  • NCT03001973

    High Quality Evidence of Chinese Lupus Nephritis (HELP)

    Research · Sun Yat-sen University

    The First Affiliated Hospital, Sun Yat-sen University, Guangzhou

    Registry updated 2026-09-15

  • NCT07814664

    Ivarmacitinib Versus Glucocorticoids in Mild-to-Moderate Systemic Lupus Erythematosus

    Trial Treatment · Phase 2/3 · Chinese SLE Treatment And Research Group

    Peking Union Medical College Hospital, Beijing

    Registry updated 2026-09-11

  • NCT07215663

    Clinical Study of Cizutamig in Systemic Lupus Erythematosus

    Trial Treatment · Phase 1 · Candid Therapeutics

    Chinese Academy of Medical Sciences and Peking Union Medical College Hospital, Beijing · Xiangya Hospital of Central South University, Changsha · West China Hospital of Sichuan University, Chengdu · The Third Affiliated Hospital,Sun Yat-Sen University, Guangzhou · Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou · Guangdong Provincial People's Hospital, Guangzhou · The First Affiliated Hospital, Sun Yat-sen University, Guangzhou · Nanfang Hospital, Southern Medical University, Guangzhou · Henan University of Science and Technology-The First Affiliated Hospital, Luoyang · The First Affiliated Hospital of NanChang University, Nanchang · The Second Affiliated Hospital of Nanchang University, Nanchang · Renji Hospital Shanghai Jiao Tong University School of Medicine, Shanghai · The First Hospital of China Medical University, Shenyang · Second hospital of Shanxi Medical University, Taiyuan · Tianjin Medical University General Hospital, Tianjin · The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an · The First Affiliated Hospital of Zhengzhou University, Zhengzhou

    Registry updated 2026-09-02

  • NCT06314282

    INTERSTELLAR - International Study Evaluating Lupus Outcomes After Anifrolumab Real World Use

    Research · AstraZeneca

    Guangzhou · Hong Kong · Shenzhen · Zhongshan · Zhuhai

    Registry updated 2026-09-01

  • NCT06513429

    IM19 CAR-T Cell Therapy in Refractory Systemic Lupus Erythematosus (SLE)

    Trial Treatment · Peking University Third Hospital

    Peking Universitiy Third Hospital, Beijing

    Registry updated 2026-08-31

  • NCT07767188

    A Trial to Explore the Efficacy and Safety of O-triple as Initial Therapy in the Active Lupus Nephritis Patients (INITIAL Trial)

    Trial Treatment · Phase 3 · Zhao Minghui

    Peking University First Hospital, Beijing · Fujian Medical University Union Hospital, Fuzhou · Guangdong Provincial People's Hospital, Guangzhou · Zhujiang Hospital of Southern Medical University, Guangzhou · The First Affiliated Hospital of Harbin Medical University, Harbin · The Affiliated Hospital of Southwest Medical University, Luzhou · The First Affiliated Hospital of NanChang University, Nanchang · Jiangsu Province Hospital, Nanjing · Shengjing Hospital affiliated to China Medical University, Shenyang · Tianjin Medical University General Hospita, Tianjin · The First Affiliated Hospital of Xinjiang Medical University, Ürümqi · The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an · The affiliated hospital of xuzhou medical university, Xuzhou · Yantai Yuhuangding Hospital, Yantai

    Registry updated 2026-08-26

  • NCT06711146

    Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Moderate to Severe Active SLE Clinical Research

    Trial Treatment · Early phase 1 · Zhejiang University

    The first affiliated hospital of medical college of zhejiang university, Hangzhou

    Registry updated 2026-08-24

  • NCT07515014

    A Study of E6742 in Participants With Systemic Lupus Erythematosus

    Trial Treatment · Phase 2 · Eisai Co., Ltd.

    Beijing Friendship Hospital, Capital Medical University - PPDS, Beijing · Peking Union Medical College Hospital - East Campus, Beijing · The First Affiliated Hospital of Bengbu Medical University, Bengbu · Jilin Province People's Hospital, Changchun · The Second Xiangya Hospital of Central South University, Changsha · West China Hospital,Sichuan University, Chengdu · The Second Affiliated Hospital of Chongqing Medical University - Yuzhong Campus, Chongqing · Nanfang Hospital Southern Medical University - PPDS, Guangzhou · The Third Affiliated Hospital,Sun Yat-Sen University, Guangzhou · Guangdong Provincial People's Hospital, Guangzhou · The Affiliated Hospital of Guizhou Medical University, Guiyang · The Second Affiliated Hospital, Zhejiang University School of Medicine - Jiefanglu Campus, Hangzhou · Jiujiang No.1 People's Hospital, Jiujiang · First Affiliated Hospital of Kunming Medical University, Kunming · Linfen Central Hospital, Linfen · The First Affiliated Hospital of Henan Science and Technology University - Jinghua Campus, Luoyang · The First Affiliated Hospital of Nanchang University - Donghu Campus, Nanchang · Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School-Main, Nanjing · The First Affiliated Hospital of Guangxi Medical University, Nanning · Pingxiang People's Hospital, Pingxiang · the First Affiliated Hospital of Shantou University Medical College, Shantou · The First Affiliated Hospital of Soochow University - Pinghailu Campus, Suzhou · The Second Affiliated Hospital of Soochow University, Suzhou · Shanxi Bethune Hospital, Taiyuan · First Hospital of Shanxi Medical University, Taiyuan · Xinxiang Central Hospital, Xinxiang · Yichang Central People's Hospital (Xiling Campus), Yichang · People's Hospital of Ningxia Hui Aotonomous Region, Yinchuan

    Registry updated 2026-08-21

  • NCT06801119

    Efficacy and Safety of HN2301 in Autoimmune Diseases(AIDs)

    Trial Treatment · Phase 1 · Shenzhen MagicRNA Biotechnology Co., Ltd

    The First Affiliated Hospital of University of Science and Technology of China, Hefei

    Registry updated 2026-08-12

  • NCT07523282

    Safety and Preliminary Efficacy of HN2302 in Patients With Autoimmune Diseases

    Trial Treatment · Phase 1 · Shenzhen MagicRNA Biotechnology Co., Ltd

    The First Affiliated Hospital of University of Science and Technology of China, Hefei

    Registry updated 2026-08-12

  • NCT07760155

    A Phase 2 Study on the Safety and Efficacy of the Anti-BAFF-R Monoclonal Antibody, ESG206, in Patients With Systemic Lupus Erythematosus

    Trial Treatment · Phase 2 · Shanghai Escugen Biotechnology Co., Ltd

    Changde First People's Hospital, Changde · Xiangya Hospital Central South University, Changsha · Second Affiliated Hospital of Guilin Medical University, Guilin · Affiliated Hospital of Hebei Engineering University, Handan · Huzhou third people's Hospital, Huzhou · Jinhua Municipal Central Hospital, Jinhua · Linfen Central Hospital, Linfen · Liupanshui Shougang Shuigang Hospital, Liupanshui · Loudi Central Hospital, Loudi · Mianyang Central Hospital, Mianyang · Affiliated Hospital of North Sichuan Medical College, Nanchong · Ningbo Medical Center Lihuili Hospital, Ningbo · Renji Hospital Shanghai Jiao Tong University School of Medicine, Shanghai · Shanghai Tongji Hospital, Shanghai · Shenzhen Third People's Hospital, Shenzhen · Second Hospital of Hebei Medical University, Shijiazhuang · Xuzhou Central Hospital, Xuzhou · Zhongshan Traditional Chinese Medicine Hospital, Zhongshan · Zhuzhou Central Hospital, Zhuzhou · Zibo Central hospital, Zibo

    Registry updated 2026-08-12

  • NCT07483346

    IASO-782 in Systemic Lupus Erythematosus

    Trial Treatment · Phase 1 · Shanghai IASO Biotechnology Co., Ltd

    Affiliated Hangzhou First People's Hospital, Westlake University School of Medicine, Hangzhou · The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou · Huzhou Central Hospital, Huzhou · The First Hospital Of Jiaxing, Jiaxing

    Registry updated 2026-08-10

  • NCT07751315

    A Study of QLS2404 Injection in Healthy Participants and Participants With Rheumatic Autoimmune Diseases

    Trial Treatment · Phase 1 · Qilu Pharmaceutical Co., Ltd.

    West China Hospital of Sichuan University, Chengdu

    Registry updated 2026-08-07

  • NCT06947460

    CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH

    Trial Treatment · Phase 1/2 · Beijing GoBroad Hospital

    Beijing

    Registry updated 2026-07-30

  • NCT07719140

    Childhood-onset Lupus Nephritis Initial Glucocorticoid-dose Harmonization Trial (LIGHT Trial)

    Trial Treatment · Phase 4 · Peking Union Medical College Hospital

    Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing · Beijing Children's Hospital, Capital Medical University, Beijing · Jilin University, Changchun · The Second Xiangya Hospital of Central South University, Changsha · Chidren's Hospital of Chongqing Medical University, Chongqing · Children's Hospital of Nanjing Medical University, Nanjing · Children's Hospital Of Fudan University, Shanghai · Shenzhen Children's Hospital, Shenzhen

    Registry updated 2026-07-22

  • NCT07596680

    CD19/BCMA-Targeted Universal CAR-T Cell Injection for the Treatment of Autoimmune Diseases

    Trial Treatment · Early phase 1 · Nanjing Bioheng Biotech Co., Ltd.

    Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai

    Registry updated 2026-07-16

  • NCT07706998

    Application of the AI Platform iLN Based on DeepSeek in the Teaching of Lupus Nephritis

    Trial Treatment · Nanjing University

    Nanjing University, Nanjing

    Registry updated 2026-07-16

  • NCT06857214

    A Study of GNC-038 Tetra-specific Antibody Injection in Patients With Systemic Lupus Erythematosus

    Trial Treatment · Phase 1 · Sichuan Baili Pharmaceutical Co., Ltd.

    Renji Hospital Shanghai Jiao Tong University School of Medicine, Shanghai

    Registry updated 2026-07-10

  • NCT07509892

    A Clinical Trial on the Efficacy and Safety of TQH3906 in the Treatment of Systemic Lupus Erythematosus

    Trial Treatment · Phase 2 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

    Anyang People's Hospital, Anyang · Beijing Chao-Yang Hospital, Capital Medical University, Beijing · The First Affillated Hospital of Bengbu Medical Universit, Bengbu · Bozhou People's Hospital, Bozhou · DAQING OILFIELD GENERAL HOSPITAL DAQING Jilin Provincial People's Hospital, Changchun · The First Hospital of Jilin University, Changchun · Hunan University of Medicine General Hospital, Changsha · Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing · Daqing Oilfield General Hospital, Daqing · The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou · Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou · The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou · Jiangmen Central Hospital, Jiangmen · Jingzhou Central Hospital, Jingzhou · Gansu Provincial People's Hospital, Lanzhou · Linfen Central Hospital, Linfen · The First Affiliated Hospital of NanChang University, Nanchang · Jiansu PeopinceHospital, Nanjing · The First Affiliated Hospital of Guangxi Medical University, Nanning · The Second Affiliated Hospital of Guangxi Medical University, Nanning · Puyang Oilfield General Hospital, Puyang · Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai · Shenzhen Second People's Hospital, Shenzhen · Taizhou Central Hospital, Taizhou · Tianjin Medical University General Hospital, Tianjin · Weifang People's Hospital, Weifang · Tongji Hospital Tongji Medical College of Hust, Wuhan · The Second Affiliated Hospital of Air Force Medical University, Xi’an · The First Affiliated Hospital of Air Force Medical University, Xi’an · Xuchang Central Hospital, Xuchang · The First People's Hospital of Yibin, Yibin · Yichang Central People's Hospital, Yichang · The First Affiliated Hospital of Henan University of CM, Zhengzhou · Zhuzhou Central Hospital, Zhuzhou · The Affiliated Hospital of Zunyi Medical University, Zunyi

    Registry updated 2026-07-08

  • NCT06285279

    The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases

    Trial Treatment · Phase 1 · Nanjing University School of Medicine

    Jinling Hospital, Nanjing

    Registry updated 2026-07-06

All Lupus (SLE) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Under construction, not live – Lupus (SLE) trials in China – Frontlight Research